Balchem Corp
BCPC156.300USD
-2.420-1.52%
Fechamento 12/19, 16:00（ET）Cotações atrasadas em 15 min
5.06BValor de mercado
33.90P/L TTM
Mais detalhes de Balchem Corp Empresa
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Informações de Balchem Corp
Código da empresaBCPC
Nome da EmpresaBalchem Corp
Data de listagemJun 03, 1986
CEOHarris (Theodore L)
Número de funcionários1361
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 03
Endereço- -
Cidade- -
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
País- -
Código postal- -
Telefone- -
Site- -
Código da empresaBCPC
Data de listagemJun 03, 1986
CEOHarris (Theodore L)
Executivos da empresa Balchem Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Por RegiãoUSD
Nome
Receita
Proporção
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Distribuição de ações
Atualizado em: qua, 8 de out
Atualizado em: qua, 8 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Outro
63.60%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Outro
63.60%
Tipos de investidores
Investidores
Proporção
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.69%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
Outro
6.56%
Participação acionária institucional
Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
692
30.08M
92.73%
+17.89K
2025Q3
707
30.06M
92.66%
+267.74K
2025Q2
685
29.78M
92.71%
+58.29K
2025Q1
661
29.74M
93.11%
-556.18K
2024Q4
638
29.76M
94.56%
+6.32K
2024Q3
611
29.83M
94.33%
+196.23K
2024Q2
600
29.66M
94.99%
-187.86K
2024Q1
588
29.84M
94.20%
-559.06K
2023Q4
578
29.57M
93.53%
+265.95K
2023Q3
565
29.33M
93.21%
-102.61K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
Ver Mais
Invesco S&P SmallCap Materials ETF
Proporção6.89%
Invesco S&P SmallCap Quality ETF
Proporção1.2%
First Trust Horizon Managed Vol Small/Mid ETF
Proporção1.05%
ProShares Russell 2000 Dividend Growers ETF
Proporção0.91%
Invesco S&P SmallCap Low Volatility ETF
Proporção0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporção0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporção0.64%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporção0.57%
Parametric Equity Premium Income ETF
Proporção0.56%
Dividendo
Um total de
104.59M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Dec 10, 2025
BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025
Dec 23, 2025
Jan 20, 2026
Dec 23, 2025
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Balchem Corp?
Os cinco principais acionistas de Balchem Corp são:
BlackRock Institutional Trust Company, N.A. detém 4.44M Ações, representando 13.67% do total de Ações.
The Vanguard Group, Inc. detém 3.89M Ações, representando 11.99% do total de Ações.
Conestoga Capital Advisors, LLC detém 1.15M Ações, representando 3.54% do total de Ações.
State Street Investment Management (US) detém 1.23M Ações, representando 3.78% do total de Ações.
Wasatch Global Investors Inc detém 960.09K Ações, representando 2.96% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 4.44M Ações, representando 13.67% do total de Ações.
The Vanguard Group, Inc. detém 3.89M Ações, representando 11.99% do total de Ações.
Conestoga Capital Advisors, LLC detém 1.15M Ações, representando 3.54% do total de Ações.
State Street Investment Management (US) detém 1.23M Ações, representando 3.78% do total de Ações.
Wasatch Global Investors Inc detém 960.09K Ações, representando 2.96% do total de Ações.
Quais são os três principais tipos de acionistas de Balchem Corp?
Os três principais tipos de acionistas da Balchem Corp são:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
Quantas instituições possuem ações da Balchem Corp (BCPC)?
Em 2025Q4, 692 instituições possuíam ações da Balchem Corp, com valor de mercado aproximado de 30.08M, representando 92.73% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em 0.07%.
Qual é a maior fonte de receita da Balchem Corp?
Em FY2025Q2, o segmento de negócios Product Sales Revenue gerou a maior receita para Balchem Corp, totalizando 255.04M e representando 99.83% da receita total.
